VectivBio Statements
VE
Data from VectivBio`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
31 Dec, 2022
Next reporting period:
29 Jun, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
VectivBio Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
36.442
0
14.622
0
49.602
60.4 %
0
-49.602
-60.4 %
0
-13.626
0
—
0
-63.228
-108 %
0
0.081
0
-63.309
-108.1 %
0
-1.193
53.05
—
—
100
—
0
—
—
0
37.511
0
19.29
0
30.922
-24.8 %
0
-30.922
24.8 %
0
0.522
0
—
0
-30.4
27.3 %
0
0.026
0
-30.426
27.4 %
0
-0.674
45.167
—
—
100
—
0
—
—
0
23.686
0
17.439
0
41.125
-9.8 %
0
-41.125
9.8 %
0
-0.702
0
—
0
-41.827
7.3 %
0
0.064
0
-41.891
7.2 %
0
-1.067
39.257
—
—
100
—
0
—
—
0
26.494
0
19.097
0
45.591
10.7 %
0
-45.591
-10.7 %
0
0.473
0
—
0
-45.118
-6.7 %
0
—
0
-45.118
-6.7 %
0
-1.326
34.015
—
—
100
—
0
—
—
0
32.375
0
8.821
0
41.196
156.4 %
0
-41.196
-156.4 %
0
-1.084
0
0.014
0
-42.266
-139.1 %
0
—
0
-42.266
-139.1 %
0
-1.243
34.015
—
—
100
—
0
—
—
0
10.66
0
5.405
0
16.065
—
0
-16.065
—
0
-1.598
0
-0.014
0
-17.677
—
0
—
0
-17.677
—
0
-0.52
34.015